The Globe and Mail3m
CVS Health bulks its board up to 16 members, adds hedge fund CEO
The additions shouldn’t be surprising after Glenview acquired its stake and made public comments on the company, Leerink Partners analyst Michael Cherny said in a note. He added that the board ...
bovnews9m
What’s Causing MannKind Corp (MNKD) Stock’s 48.15% Jump Over the Last Six Months?
On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.8 which represents a decrease of $-0.22 or -3.13% from the prior close of $7.02. The stock opened at $7.05 and touched a low ...
bovnews2h
Geron Corp (GERN) Reported a -705.46% Operating Margin Last Year—What’s the Real Story?
On Friday, Geron Corp (GERN) stock saw a decline, ending the day at $3.66 which represents a decrease of $-0.05 or -1.35% from the prior close of $3.71. The stock opened at $3.73 and touched a low of ...
Wells Fargo Sticks to Their Hold Rating for Cigna (CI)
Wells Fargo analyst Steve Baxter maintained a Hold rating on Cigna (CI – Research Report) today and set a price target of $370.00. The ...
CVS adds four new board members in deal with Glenview Capital
CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. The ...
Investor's Business Daily on MSN2h
How A Side Effect Has Wiped Out Nearly 73% Of Neurogene's Value In A Week
Neurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett Syndrome ...